Calamos Advisors’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-20,693
Closed -$1.84M 665
2017
Q1
$1.84M Sell
20,693
-47
-0.2% -$3.87K 0.01% 514
2016
Q4
$1.47M Sell
20,740
-279
-1% -$20.8K 0.01% 536
2016
Q3
$1.66M Buy
21,019
+21
+0.1% +$1.79K 0.01% 478
2016
Q2
$1.91M Buy
20,998
+8
+0% +$677 0.01% 463
2016
Q1
$1.78M Buy
20,990
+1,309
+7% +$97.4K 0.01% 473
2015
Q4
$1.55M Hold
19,681
0.01% 490
2015
Q3
$1.39M Buy
19,681
+7
+0% +$576 0.01% 512
2015
Q2
$1.77M Sell
19,674
-20,457
-51% -$1.97M 0.01% 504
2015
Q1
$4.03M Buy
40,131
+23
+0.1% +$2.32K 0.03% 403
2014
Q4
$4.03M Buy
40,108
+208
+0.5% +$20.7K 0.03% 380
2014
Q3
$3.84M Hold
39,900
0.03% 359
2014
Q2
$3.72M Buy
39,900
+2,900
+8% +$254K 0.02% 372
2014
Q1
$3.08M Hold
37,000
0.02% 382
2013
Q4
$3.1M Sell
37,000
-154,000
-81% -$12.5M 0.02% 379
2013
Q3
$14.2M Hold
191,000
0.09% 217
2013
Q2
$15.1M Buy
+191,000
New +$15.3M 0.1% 198

Other funds holding MJN

Calamos Advisors's MJN Position: Q2 2017 in Review

Calamos Advisors sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 20,693 shares — an estimated $1.84M sold.

Calamos Advisors first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $15.1M in Q2 2013. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Calamos Advisors reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Calamos Advisors sold 20,693 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $1.84M.
  • Calamos Advisors first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Calamos Advisors's Mead Johnson Nutrition Company position peaked at $15.1M in Q2 2013.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Calamos Advisors's 13F filing for Q2 2017, filed 9 Aug 2017.